Basic Information
ID: ALA4256832
Type: Binding
Description: Inhibition of cIAP2 in human PANC1 cells assessed as potentiation of gemcitabine induced growth inhibition at 15 uM pretreated with gemcitabine for 24 hrs followed by compound addition and measured after 24 hrs by ATPlite 1Step luminescence assay
Format: BAO_0000219
Organism: Homo sapiens
Target: Baculoviral IAP repeat-containing protein 3(ALA5335)
Document: ALA4251755
Inhibition of cIAP2 in human PANC1 cells assessed as potentiation of gemcitabine induced growth inhibition at 15 uM pretreated with gemcitabine for 24 hrs followed by compound addition and measured after 24 hrs by ATPlite 1Step luminescence assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4256832
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 498.65 | 2.81 | 2.81 |
| 580.60 | 3.72 | 3.72 |